Skip to main content

Table 1 Summary of Findings

From: High-flow nasal cannula versus non-invasive ventilation for acute hypercapnic respiratory failure in adults: a systematic review and meta-analysis of randomized trials

Certainty assessment

No of patients

Effect

Certainty

Importance

No of studies

Study design

Risk of bias

Inconsistency

Indirectness

Imprecision

Other considerations

HFNC

NIV

Relative (95% CI)

Absolute (95% CI)

Mortality

4

Randomized trials

Not seriousa

Not serious

Not serious

Very seriousb

None

18/127 (14.2%)

21/123 (17.1%)

RR 0.86

(0.48 to 1.56)

2 fewer per 100

(from 9 fewer to 10 more)

Low

 

Intubation

4

Randomized trials

Not seriousa

Not serious

Not serious

Very seriousc

None

19/141 (13.5%)

23/134 (17.2%)

RR 0.80

(0.46 to 1.39)

3 fewer per 100

(from 9 fewer to 7 more)

Low

 

ICU length of stay

2

Randomized trials

Not serious

Seriousd

Not serious

Seriouse

None

34

33

MD 0.08 higher

(1.16 lower to 1.32 higher)

Low

 

Hospital length of stay

4

Randomized trials

Not serious

Not serious

Not serious

Not seriousf

None

178

174

MD 0.82 lower

(1.83 lower to 0.2 higher)

High

 

Comfort

2

Randomized trials

seriousg

Serioush

Not serious

Seriousi

None

49

52

SMD 0.32 lower

(1.78 lower to 1.13 higher)

Very low

 

Dyspnea

4

Randomized trials

seriousg

Not serious

Not serious

Seriousj

None

98

93

MD 0.04 lower

(0.54 lower to 0.45 higher)

Low

 

PaO2

5

Randomized trials

Not seriousa

Not serious

Not serious

Not seriousk

None

215

212

MD 0.78 lower

(4.18 lower to 2.62 higher)

High

 

PaCO2

7

Randomized trials

Not seriousa

Seriousl

Not serious

Not seriousk

None

245

242

MD 1.87 lower

(5.34 lower to 1.6 higher)

Moderate

 

Respiratory rate

5

Randomized trials

Not seriousa

Not serious

Not serious

Seriousm

None

119

115

MD 0.85 lower

(1.88 lower to 0.18 higher)

Moderate

 
  1. CI Confidence interval; MD Mean difference; RR Risk ratio; SMD Standardized mean difference
  2. a. All probably low risk except for greater than 10% dropout rate and more outcomes reported than described in methods in single study
  3. b. Minimally important difference threshold of 3% is crossed (likely wide CI due to small sample size) and very few events
  4. c. Minimally important difference threshold of 5% is crossed (likely wide CI due to small sample size) and very few events
  5. d. Point estimates significantly different, I squared > 50%
  6. e. Minimally important difference threshold of 2 days.is met. Imprecision due to small sample size
  7. f. Minimally important difference threshold of 2 days is met
  8. g. Subjective outcome which will be significantly affected by lack of blinding
  9. h. Significant heterogeneity, I squared > 50%, different point estimates without overlapping confidence intervals, P < 0.1
  10. i. Minimally important difference threshold of 1SD was crossed. Imprecision due to small number of participants
  11. j. Minimally important difference threshold of 1SD. Imprecision due to small number of participants
  12. k. For the minimally important difference (threshold 15 mmHg), we considered no difference in PCO2 to be significant and there was a large number of total patients in the analysis
  13. l. Significant difference in confidence intervals, borderline high I squared and P value < 0.1
  14. m. Minimally important difference of 10 breaths per minute. Imprecision due to small number of participants